| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.0M | +13.0% |
| Cost of Revenue | $5.5M | +25.1% |
| Gross Profit | $1.5M | -16.7% |
| R&D Expense | $13.6M | +70.8% |
| SG&A Expense | $15.3M | +37.8% |
| Operating Income | -$33.5M | -58.5% |
| Pre-tax Income | -$31.9M | -60.9% |
| Income Tax | $59K | -9.2% |
| Net Income | -$32.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.9M | +96.2% |
| Short-term Investments | $15.7M | -46.5% |
| Accounts Receivable | $1.6M | -12.9% |
| Inventory | $2.6M | +22.0% |
| Current Assets | $40.5M | -8.2% |
| Total Assets | $46.8M | -1.8% |
| Current Liabilities | $7.7M | +27.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.9M | -33.5% |
| Capital Expenditures | $1.4M | +268.0% |
| Investing Cash Flow | $12.6M | +178.6% |
| Financing Cash Flow | $18.5M | -50.8% |
| Free Cash Flow | -$23.3M | -38.9% |
| -60.7% |
| EPS (Basic) | -$0.76 | +7.3% |
| EPS (Diluted) | -$0.76 | +7.3% |
| Total Liabilities |
| $10.7M |
| +31.7% |
| Stockholders' Equity | $36.1M | -8.6% |